trelstar has been researched along with Uterine-Cervical-Neoplasms* in 2 studies
2 other study(ies) available for trelstar and Uterine-Cervical-Neoplasms
Article | Year |
---|---|
Regression of the malignant aspects of intraepithelial neoplasias following an LH-RH agonist treatment and detection of human papillomavirus by molecular hybridization.
Patients presenting genital intraepithelial neoplasia and/or flat condyloma were treated with DTrp6-LH-RH (triptorelin) to induce a transitory suppression of estrogens. This treatment led in some cases to a complete clinical and histological regression accompanied by a disappearance of human papillomavirus sequences as detected by molecular hybridization. Topics: Antineoplastic Agents; Female; Gonadotropin-Releasing Hormone; Humans; Papillomaviridae; Triptorelin Pamoate; Tumor Virus Infections; Uterine Cervical Neoplasms | 1989 |
Triptorelin in treatment of cervical and vaginal dysplasia related to papillomavirus.
Topics: Adult; Antineoplastic Agents; Condylomata Acuminata; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Papillomaviridae; Time Factors; Triptorelin Pamoate; Tumor Virus Infections; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1988 |